» Articles » PMID: 26332335

Utilization of Community Pharmacy Space to Enhance Privacy: a Qualitative Study

Overview
Journal Health Expect
Publisher Wiley
Specialty Public Health
Date 2015 Sep 3
PMID 26332335
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Community pharmacists require access to consumers' information about their medicines and health-related conditions to make informed decisions regarding treatment options. Open communication between consumers and pharmacists is ideal although consumers are only likely to disclose relevant information if they feel that their privacy requirements are being acknowledged and adhered to.

Objective: This study sets out to explore community pharmacy privacy practices, experiences and expectations and the utilization of available space to achieve privacy.

Methods: Qualitative methods were used, comprising a series of face-to-face interviews with 25 pharmacists and 55 pharmacy customers in Perth, Western Australia, between June and August 2013.

Results: The use of private consultation areas for certain services and sensitive discussions was supported by pharmacists and consumers although there was recognition that workflow processes in some pharmacies may need to change to maximize the use of private areas. Pharmacy staff adopted various strategies to overcome privacy obstacles such as taking consumers to a quieter part of the pharmacy, avoiding exposure of sensitive items through packaging, lowering of voices, interacting during pharmacy quiet times and telephoning consumers. Pharmacy staff and consumers regularly had to apply judgement to achieve the required level of privacy.

Discussion: Management of privacy can be challenging in the community pharmacy environment, and on-going work in this area is important. As community pharmacy practice is increasingly becoming more involved in advanced medication and disease state management services with unique privacy requirements, pharmacies' layouts and systems to address privacy challenges require a proactive approach.

Citing Articles

Barriers to effective communication in UAE community pharmacies: general public perspectives on enhancing patient-pharmacist interaction and policy development.

Kharaba Z, Al-Azayzih A, Al-Azzam S, Jarab A, Hasan H, Rahhal D J Pharm Policy Pract. 2025; 18(1):2460744.

PMID: 39958939 PMC: 11827033. DOI: 10.1080/20523211.2025.2460744.


Bridging gaps in medication therapy management at community health centers: A mixed-methods study on patient perceptions and pharmacists' preparedness.

Yasin N, Kurniawati F, Ridhayani F Explor Res Clin Soc Pharm. 2025; 17():100554.

PMID: 39811096 PMC: 11732552. DOI: 10.1016/j.rcsop.2024.100554.


Privacy in Community Pharmacies in Saudi Arabia: A Cross-Sectional Study.

Alrasheed M, Alfageh B, Almohammed O Healthcare (Basel). 2024; 12(17).

PMID: 39273764 PMC: 11394820. DOI: 10.3390/healthcare12171740.


Comparative evaluation of access to emicizumab (Hemlibra®) for people with haemophilia A in community and hospital pharmacies in France.

Cabon M, Chamouard V, Freyssenge J, Fraticelli L Eur J Public Health. 2024; 34(5):866-871.

PMID: 39209530 PMC: 11430965. DOI: 10.1093/eurpub/ckae131.


Exploring the role of community pharmacies as a harm reduction environment for anabolic-androgenic steroid consumers: triangulating the perspectives of consumers and pharmacists.

Piatkowski T, Benn S, Ayurzana L, King M, McMillan S, Hattingh L Harm Reduct J. 2024; 21(1):59.

PMID: 38481218 PMC: 10935940. DOI: 10.1186/s12954-024-00972-5.


References
1.
Hattingh H . The regulation of pharmacy ownership in Australia: the potential impact of changes to the health landscape. J Law Med. 2011; 19(1):147-54. View

2.
Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips-Howard P . How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives. Res Social Adm Pharm. 2012; 10(2):272-84. DOI: 10.1016/j.sapharm.2012.05.006. View

3.
Anderson C, Blenkinsopp A, Armstrong M . Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002. Health Expect. 2004; 7(3):191-202. PMC: 5060240. DOI: 10.1111/j.1369-7625.2004.00274.x. View

4.
Hattingh H, Knox K, Fejzic J, McConnell D, Fowler J, Mey A . Privacy and confidentiality: perspectives of mental health consumers and carers in pharmacy settings. Int J Pharm Pract. 2014; 23(1):52-60. DOI: 10.1111/ijpp.12114. View

5.
Knox K, Fejzic J, Mey A, Fowler J, Kelly F, McConnell D . Mental health consumer and caregiver perceptions of stigma in Australian community pharmacies. Int J Soc Psychiatry. 2013; 60(6):533-43. DOI: 10.1177/0020764013503149. View